NicOx fixes on ophthalmology and begins metamorphosis
This article was originally published in Scrip
Executive Summary
NicOx has announced its intention to become an international integrated mid-sized commercial player in the ophthalmology market, marking a significant departure from its previous business model. It is looking for other options for most of its current pipeline.